Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 333

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome

Open access
Keddie, Stephen, Pakpoor, Julia, Mousele, Christina, Pipis, Menelaos, Machado, Pedro M, Foster, Mark, Record, Christopher J, Keh, Ryan Y S, Fehmi, Janev, Paterson, Ross W, Bharambe, Viraj, Clayton, Lisa M, Allen, Claire, Price, Olivia, Wall, Jasmine, Kiss-Csenki, Annamaria, Rathnasabapathi, Devi Priya, Geraldes, Ruth, Yermakova, Tatyana, King-Robson, Joshua, Zosmer, Maya, Rajakulendran, Sanjeev, Sumaria, Sheetal, Farmer, Simon F, Nortley, Ross, Marshall, Charles R, Newman, Edward J, Nirmalananthan, Niranjanan, Kumar, Guru, Pinto, Ashwin A, Holt, James, Lavin, Tim M, Brennan, Kathryn M, Zandi, Michael S, Jayaseelan, Dipa L, Pritchard, Jane, Hadden, Robert D M, Manji, Hadi, Willison, Hugh J, Rinaldi, Simon, Carr, Aisling S, Lunn, Michael P·2021·Brain

Abstract

Reports of Guillain-Barré syndrome (GBS) have emerged during the Coronavirus disease 2019 (COVID-19) pandemic. This epidemiological and cohort study sought to investigate any causative association between COVID-19 infection and GBS. The epidemiology of GBS cases reported to the UK National Immunoglobulin Database was studied from 2016 to 2019 and compared to cases reported during the COVID-19 pandemic. Data were stratified by hospital trust and region, with numbers of reported cases per month. UK population data for COVID-19 infection were collated from UK public health bodies. In parallel, but separately, members of the British Peripheral Nerve Society prospectively reported incident cases of GBS during the pandemic at their hospitals to a central register. The clinical features, investigation findings and outcomes of COVID-19 (definite or probable) and non-COVID-19 associated GBS cases in this cohort were compared. The incidence of GBS treated in UK hospitals from 2016 to 2019 was 1.65–1.88 per 100 000 individuals per year. GBS incidence fell between March and May 2020 compared to the same months of 2016–19. GBS and COVID-19 incidences during the pandemic also varied between regions and did not correlate with one another (r = 0.06, 95% confidence interval: −0.56 to 0.63, P = 0.86). In the independent cohort study, 47 GBS cases were reported (COVID-19 status: 13 definite, 12 probable, 22 non-COVID-19). There were no significant differences in the pattern of weakness, time to nadir, neurophysiology, CSF findings or outcome between these groups. Intubation was more frequent in the COVID-19 affected cohort (7/13, 54% versus 5/22, 23% in COVID-19-negative) attributed to COVID-19 pulmonary involvement. Although it is not possible to entirely rule out the possibility of a link, this study finds no epidemiological or phenotypic clues of SARS-CoV-2 being causative of GBS. GBS incidence has fallen during the pandemic, which may be the influence of lockdown measures reducing transmission of GBS inducing pathogens such as Campylobacter jejuni and respiratory viruses.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/brain/awaa433

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 333

Metadata

Authors
Keddie, S., Pakpoor, J., Mousele, C., Pipis, M., Machado, P. M., Foster, M., Record, C. J., Keh, R. Y. S., Fehmi, J., Paterson, R. W., Bharambe, V., Clayton, L. M., Allen, C., Price, O., Wall, J., Kiss-Csenki, A., Rathnasabapathi, D. P., Geraldes, R., Yermakova, T., King-Robson, J., Zosmer, M., Rajakulendran, S., Sumaria, S., Farmer, S. F., Nortley, R., Marshall, C. R., Newman, E. J., Nirmalananthan, N., Kumar, G., Pinto, A. A., Holt, J., Lavin, T. M., Brennan, K. M., Zandi, M. S., Jayaseelan, D. L., Pritchard, J., Hadden, R. D. M., Manji, H., Willison, H. J., Rinaldi, S., Carr, A. S., & Lunn, M. P.
Venue
Brain
Published
2020-12-14
Volume
144
Issue
2
Pages
682-693
ISSN
  • 0006-8950 (ISSN-L)
  • 1460-2156
OpenAlex
W3112455590
Cited by
333
References
33
FWCI
23.93
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. https://app.cochat.ai/papers/10.1093/brain/awaa433
The paper
Keddie, S., Pakpoor, J., Mousele, C., Pipis, M., Machado, P. M., Foster, M., Record, C. J., Keh, R. Y. S., Fehmi, J., Paterson, R. W., Bharambe, V., Clayton, L. M., Allen, C., Price, O., Wall, J., Kiss-Csenki, A., Rathnasabapathi, D. P., Geraldes, R., Yermakova, T., . . . Lunn, M. P. (2021). Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome. Brain. https://doi.org/10.1093/brain/awaa433

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.